Stokes Family Office’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Sell
2,350
-1,449
-38% -$137K 0.03% 251
2026
Q1
$299K Sell
3,799
-3,702
-49% -$298K 0.03% 234
2025
Q4
$545K Buy
7,501
+54
+0.7% +$3.83K 0.05% 184
2025
Q3
$503K Sell
7,447
-68
-0.9% -$4.39K 0.05% 180
2025
Q2
$475K Sell
7,515
-75,871
-91% -$4.42M 0.05% 168
2025
Q1
$4.59M Sell
83,386
-35,890
-30% -$2.01M 0.52% 47
2024
Q4
$6.61M Buy
119,276
+3,704
+3% +$217K 0.71% 30
2024
Q3
$7.06M Buy
115,572
+16,588
+17% +$996K 0.77% 28
2024
Q2
$5.86M Sell
98,984
-43,470
-31% -$2.5M 0.69% 29
2024
Q1
$8.2M Buy
142,454
+47,365
+50% +$2.63M 1.02% 24
2023
Q4
$5.27M Buy
+95,089
New +$4.9M 0.71% 35

Other funds holding EMXC

Stokes Family Office's EMXC Position: Q2 2026 in Review

Stokes Family Office reduced its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 38% in Q2 2026, selling an estimated $137K and leaving 2,350 shares worth $240K. The position accounts for 0.03% of the portfolio, ranked #251.

Stokes Family Office first reported a position in EMXC in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.2M in Q1 2024. 1,024 funds tracked by Wall St. Rank hold EMXC as of Q2 2026.

  • Stokes Family Office held 2,350 shares of iShares MSCI Emerging Markets ex China ETF worth $240K as of Q2 2026.
  • Stokes Family Office sold 1,449 iShares MSCI Emerging Markets ex China ETF shares in Q2 2026, an estimated $137K.
  • iShares MSCI Emerging Markets ex China ETF made up 0.03% of Stokes Family Office's portfolio in Q2 2026, its #251 holding.
  • Stokes Family Office first reported a position in iShares MSCI Emerging Markets ex China ETF in Q4 2023 and has held it in 11 quarters since.
  • Stokes Family Office's iShares MSCI Emerging Markets ex China ETF position peaked at $8.2M in Q1 2024.
  • 1,024 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q2 2026.

Based on Stokes Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.